FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter SLAYBACK PHARMA LLC ANDA 210618
Letter
ANDA 210618
SLAYBACK PHARMA LLC
FDA.report
›
FDA Drug Approvals
›
SLAYBACK PHARMA LLC
›
ANDA 210618
›
Letter
Application #210618
Documents
Letter
2019-01-18
Application Sponsors
ANDA 210618
SLAYBACK PHARMA LLC
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.